SOBRsafe Inc. (NASDAQ: SOBR) CEO Shares Focus for 2024 and Successes Marking Beginning of “Broad Adoption” in Behavioral Health and Justice Segments
- SOBRsafe CEO Dave Gandini recently communicated the company’s 2023 progress in expanding its line of products as well as its sales outreach and focus for 2024; view the video here
- Last fall, SOBRsafe’s management directed the company’s sales effort toward the behavioral health and justice segments, sectors that already have embedded alcohol monitoring procedures, but need better monitoring and screening solutions
- SOBRsafe provides SOBRsure(TM) and SOBRcheck(TM), next-generation touch-based alcohol detection and monitoring solutions that fit the behavioral health and justice segments “to a tee,” according to Gandini
- As a result of its redirected efforts, the company has secured 16 new accounts in the past three months, compared to three accounts for the whole of 2023
For most of 2023, SOBRsafe (NASDAQ: SOBR), a company that provides next-generation transdermal alcohol detection and monitoring solutions, took a broad approach to marketing its technology, which appeared to have near-universal applicability, according to company Chair and CEO Dave Gandini. The learnings from this initial approach have since informed SOBRsafe’s tighter focus for 2024, which is intended to help the company grow sales and generate cash flow and net income.
“What we discovered with all our outreach in 2023 was that there are businesses and services that already use different alcohol testing technologies, and, in these sectors, that use of testing is mandated. It’s not a want, it’s a need. These sectors already use alcohol detection products as a matter of standard procedure, but are hungry for evolved monitoring and screening solutions,” said Gandini, who was speaking in a recent presentation, a part of the Lytham Spotlight Series (https://nnw.fm/OxQmQ ). “So, what are these markets? Behavioral health (alcohol recovery and mental health) and what we term the ‘justice’ segment.”
Currently, legacy detection methods are used to routinely screen patients in the care of behavioral health facilities, as well as those in outpatient monitoring programs, to establish the presence or absence of alcohol. Based on breath, urine, or blood samples, these methods are considered invasive, unhygienic and degrading. In addition, they are typically analog – they require a staff member to administer the test and write the results down, making them inefficient, time-consuming, and error-prone.
Similarly, SOBRsafe uncovered opportunities within the justice segment. According to Gandini, this segment “relates to basically all things outside of police DUI screening. For example, this segment would include resident testing at halfway houses, or for proof of pre-trial sobriety. There are also employment and insurance mandates where an employee with a previous infraction is only allowed to continue working if they demonstrate sobriety every day.”
Beginning in the fourth quarter of last year, SOBRsafe management directed the company’s sales efforts toward these two segments. Contemporaneously, the company launched SOBRsure(TM), a wearable wristband that utilizes the same SOBRsafe hardware and software platform for ongoing, real-time alcohol monitoring and GPS tracking. SOBRsure(TM) complements the company’s point-of-care alcohol screening product, SOBRcheck (TM), with both products fitting the behavioral health and justice segment to a tee, according to the presentation.
In addition, Gandini also discussed the success of the company’s informed focus, saying, “We’ve secured 16 new accounts in the past three months… vs. just 3 for all of 2023. We believe that this success represents just the beginning of our broad adoption in behavioral health and justice. We believe that success breeds success and that these new relationships will help spark additional and large deals. To fuel this growth, we have a strong team of 4 direct sales professionals and 8 behavioral health field affiliates across key markets.”
SOBRsafe is also working on international expansion as well as licensing and integration. “At the end of January, we announced that we had signed a channel partnership in Australia and New Zealand to target their behavioral health and justice needs. This announcement has driven inbound interest from other countries, with conversations underway,” continued Gandini. In the meantime, SOBRsafe continues to target the more than 46,000 behavioral health facilities across the United States, where its technology could have immediate application.
To watch the presentation, please visit https://nnw.fm/tHU5F.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
- SOBRsafe CEO Dave Gandini recently communicated the company’s 2023 progress in expanding its line of products as well as its sales outreach and focus for 2024; view the video here
- Last fall, SOBRsafe’s management directed the company’s sales effort toward the behavioral health and justice segments, sectors that already have embedded alcohol monitoring procedures, but need better monitoring and screening solutions
- SOBRsafe provides SOBRsure(TM) and SOBRcheck(TM), next-generation touch-based alcohol detection and monitoring solutions that fit the behavioral health and justice segments “to a tee,” according to Gandini
- As a result of its redirected efforts, the company has secured 16 new accounts in the past three months, compared to three accounts for the whole of 2023
For most of 2023, SOBRsafe (NASDAQ: SOBR), a company that provides next-generation transdermal alcohol detection and monitoring solutions, took a broad approach to marketing its technology, which appeared to have near-universal applicability, according to company Chair and CEO Dave Gandini. The learnings from this initial approach have since informed SOBRsafe’s tighter focus for 2024, which is intended to help the company grow sales and generate cash flow and net income.
“What we discovered with all our outreach in 2023 was that there are businesses and services that already use different alcohol testing technologies, and, in these sectors, that use of testing is mandated. It’s not a want, it’s a need. These sectors already use alcohol detection products as a matter of standard procedure, but are hungry for evolved monitoring and screening solutions,” said Gandini, who was speaking in a recent presentation, a part of the Lytham Spotlight Series (https://nnw.fm/OxQmQ ). “So, what are these markets? Behavioral health (alcohol recovery and mental health) and what we term the ‘justice’ segment.”
Currently, legacy detection methods are used to routinely screen patients in the care of behavioral health facilities, as well as those in outpatient monitoring programs, to establish the presence or absence of alcohol. Based on breath, urine, or blood samples, these methods are considered invasive, unhygienic and degrading. In addition, they are typically analog – they require a staff member to administer the test and write the results down, making them inefficient, time-consuming, and error-prone.
Similarly, SOBRsafe uncovered opportunities within the justice segment. According to Gandini, this segment “relates to basically all things outside of police DUI screening. For example, this segment would include resident testing at halfway houses, or for proof of pre-trial sobriety. There are also employment and insurance mandates where an employee with a previous infraction is only allowed to continue working if they demonstrate sobriety every day.”
Beginning in the fourth quarter of last year, SOBRsafe management directed the company’s sales efforts toward these two segments. Contemporaneously, the company launched SOBRsure(TM), a wearable wristband that utilizes the same SOBRsafe hardware and software platform for ongoing, real-time alcohol monitoring and GPS tracking. SOBRsure(TM) complements the company’s point-of-care alcohol screening product, SOBRcheck (TM), with both products fitting the behavioral health and justice segment to a tee, according to the presentation.
In addition, Gandini also discussed the success of the company’s informed focus, saying, “We’ve secured 16 new accounts in the past three months… vs. just 3 for all of 2023. We believe that this success represents just the beginning of our broad adoption in behavioral health and justice. We believe that success breeds success and that these new relationships will help spark additional and large deals. To fuel this growth, we have a strong team of 4 direct sales professionals and 8 behavioral health field affiliates across key markets.”
SOBRsafe is also working on international expansion as well as licensing and integration. “At the end of January, we announced that we had signed a channel partnership in Australia and New Zealand to target their behavioral health and justice needs. This announcement has driven inbound interest from other countries, with conversations underway,” continued Gandini. In the meantime, SOBRsafe continues to target the more than 46,000 behavioral health facilities across the United States, where its technology could have immediate application.
To watch the presentation, please visit https://nnw.fm/tHU5F.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
